1027586-35-1

Upstream product

• 164931-18-4 Ser(O-t-Bu)-Lys(BOC)-2-cyclohexylethylamide 
• 189132-04-5 {4-[4-(tert-Butoxycarbonylamino-methyl)-phenylethynyl]-phenyl}-acetic acid 
• 24424-99-5 di-tert-butyl dicarbonate 
• 1798-06-7 (4-iodophenyl)acetic acid 
• 1676-75-1 N-benzyloxycarbonyl-O-t-butyl-L-serine 
• 63349-52-0 methyl 4-iodophenylacetate 
• 39959-59-6 4-iodobenzyl amine 
• 154498-13-2 methyl 2-(4-ethynylphenyl)acetate 
• 189132-01-2 4-[(N-tert-butyloxycarbonylamino)methyl]iodobenzene 
• 189132-13-6 [(S)-5-((S)-2-Benzyloxycarbonylamino-3-tert-butoxy-propionylamino)-5-(2-cyclohexyl-ethylcarbamoyl)-pentyl]-carbamic acid tert-butyl ester 
• 154498-12-1 methyl 2-(4-(2-(trimethylsilyl)ethynyl)phenyl)acetate 
• 1025975-03-4 {4-[4-(tert-Butoxycarbonylamino-methyl)-phenylethynyl]-phenyl}-acetic acid methyl ester 

Relevant academic research and scientific papers

Conformationally constrained [p-(ω-aminoalkyl)phenacetyl]-L-seryl-L- lysyl dipeptide amides as potent peptidomimetic inhibitors of Candida albicans and human myristoyl-CoA:protein N-myristoyl transferase

MyristoylCoA:protein N-myristoyltransferase (NMT) covalently attaches the 14-carbon saturated fatty acid myristate, via an amide bond, to the N- terminal glycine residues of a variety of cellular proteins. Genetic studies have shown that NMT is essential